Trial
NCT04857359
Dipraglurant (ADX48621) for the Treatment of Patients With Parkinson's Disease Receiving Levodopa-based Therapy
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Addex Pharma S.A.
Collaborators
—
Condition
Parkinson Disease
Intervention
Dipraglurant
Why stopped
Terminated prior to completing enrollment goals due to COVID-related difficulties in recruiting patients
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-08-06